Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017

David Terkelsen; Jacob Tolstrup; Camilla Hundahl Johnsen; Ole Lund; Helle Kiellberg Larsen; Peder Worning; Magnus Unemo; Henrik Westh

doi:10.2807/1560-7917.ES.2017.22.42.17-00659

Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017

David Terkelsen, Jacob Tolstrup, Camilla Hundahl Johnsen, Ole Lund, Helle Kiellberg Larsen, Peder Worning, Magnus Unemo, Henrik Westh

86 Citationer (Scopus)

Abstract

We describe a multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and azithromycin intermediate resistance in a heterosexual man in Denmark, 2017. Whole genome sequencing of the strain GK124 identified MSLT ST1903, NG-MAST ST1614 and all relevant resistance determinants including similar penA resistance mutations previously described in ceftriaxone-resistant gonococcal strains. Although treatment with ceftriaxone 0.5 g plus azithromycin 2 g was successful, increased awareness of spread of gonococcal strains threatening the recommended dual therapy is crucial.

Originalsprog	Engelsk
Tidsskrift	Eurosurveillance
Vol/bind	22
Udgave nummer	42
ISSN	1560-7917
DOI	https://doi.org/10.2807/1560-7917.ES.2017.22.42.17-00659
Status	Udgivet - okt. 2017

Adgang til dokumentet

10.2807/1560-7917.ES.2017.22.42.17-00659

Citationsformater

@article{5866f3a7724e453d9410ce2365e9ad02,

title = "Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017",

abstract = "We describe a multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and azithromycin intermediate resistance in a heterosexual man in Denmark, 2017. Whole genome sequencing of the strain GK124 identified MSLT ST1903, NG-MAST ST1614 and all relevant resistance determinants including similar penA resistance mutations previously described in ceftriaxone-resistant gonococcal strains. Although treatment with ceftriaxone 0.5 g plus azithromycin 2 g was successful, increased awareness of spread of gonococcal strains threatening the recommended dual therapy is crucial.",

keywords = "Journal Article",

author = "David Terkelsen and Jacob Tolstrup and Johnsen, {Camilla Hundahl} and Ole Lund and Larsen, {Helle Kiellberg} and Peder Worning and Magnus Unemo and Henrik Westh",

year = "2017",

month = oct,

doi = "10.2807/1560-7917.ES.2017.22.42.17-00659",

language = "English",

volume = "22",

journal = "Eurosurveillance",

issn = "1560-7917",

publisher = "Centre Europeen pour la Surveillance Epidemiologique du SIDA",

number = "42",

}

TY - JOUR

T1 - Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017

AU - Terkelsen, David

AU - Tolstrup, Jacob

AU - Johnsen, Camilla Hundahl

AU - Lund, Ole

AU - Larsen, Helle Kiellberg

AU - Worning, Peder

AU - Unemo, Magnus

AU - Westh, Henrik

PY - 2017/10

Y1 - 2017/10

N2 - We describe a multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and azithromycin intermediate resistance in a heterosexual man in Denmark, 2017. Whole genome sequencing of the strain GK124 identified MSLT ST1903, NG-MAST ST1614 and all relevant resistance determinants including similar penA resistance mutations previously described in ceftriaxone-resistant gonococcal strains. Although treatment with ceftriaxone 0.5 g plus azithromycin 2 g was successful, increased awareness of spread of gonococcal strains threatening the recommended dual therapy is crucial.

AB - We describe a multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and azithromycin intermediate resistance in a heterosexual man in Denmark, 2017. Whole genome sequencing of the strain GK124 identified MSLT ST1903, NG-MAST ST1614 and all relevant resistance determinants including similar penA resistance mutations previously described in ceftriaxone-resistant gonococcal strains. Although treatment with ceftriaxone 0.5 g plus azithromycin 2 g was successful, increased awareness of spread of gonococcal strains threatening the recommended dual therapy is crucial.

KW - Journal Article

U2 - 10.2807/1560-7917.ES.2017.22.42.17-00659

DO - 10.2807/1560-7917.ES.2017.22.42.17-00659

M3 - Journal article

C2 - 29067905

SN - 1560-7917

VL - 22

JO - Eurosurveillance

JF - Eurosurveillance

IS - 42

ER -

Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater